Chaired by Lisa Singleton and Terry Van Willson, the 2026 Breakthrough T1D Dallas Luncheon, One Step Closer, invites you to an inspiring afternoon dedicated to accelerating progress toward a world ...
Research funding will aim to decode understanding across autoimmune diseases NEW YORK, Nov. 18, 2026 — Today, leading autoimmune disease nonprofits – Breakthrough T1D (formerly JDRF), the Lupus ...
GRAMMY®-nominated musician Este Haim to Emcee Breakthrough T1D’s 53rd Annual New York City Promise Gala; Peter Hill to Be Honored as Humanitarian of the Year Cell Therapy Clinical Trial Participant ...
Today’s festivities include a “See T1D” Times Square digital billboard takeover with ads featuring Breakthrough T1D Celebrity ...
Announced during Diabetes Awareness Month, the award marks significant progress for type 1 diabetes cell therapies HAMILTON, Ont., Nov. 16, 2026 – Allarta Life Science Inc. has received an award from ...
This National Diabetes Awareness Month, we celebrate breakthroughs in approvals and access for type 1 diabetes from the last ...
Ask four people living with type 1 diabetes what cures would mean to them, and you will get four different answers. Independence. Calmness. A quiet mind. A full night’s sleep. Yet they all describe ...
Diabetes Care perspective, developed by experts across the country and endorsed by Breakthrough T1D and the Pediatric Endocrine Society, helps pediatric diabetes teams integrate teplizumab into care ...
NEW YORK and DEERFIELD, Ill., Nov. 12, 2026—Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, and the Walgreens Foundation today announced a new national ...
Throughout the project, Axent will assess key metrics such as cell viability, yield, stage-specific marker expression, and cell functionality to ensure the process meets the quality standards required ...